Pharmacological insights into the role of P2X4 receptors in behavioural regulation: Lessons from ivermectin

International Journal of Neuropsychopharmacology

Volumn 16, Issue 5, 2013, Pages 1059-1070

  Bortolato, Marco ^a   Yardley, Megan M ^a   Khoja, Sheraz ^a   Godar, Sean C ^a   Asatryan, Liana ^a   Finn, Deborah A ^b   Alkana, Ronald L ^a   Louie, Stan G ^a   Davies, Daryl L ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Anxiety; depression; ivermectin; P2X 4 purinergic receptors; pre pulse inhibition of the startle

Indexed keywords

IVERMECTIN; PURINERGIC P2X4 RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR CONTROL; CONTROLLED STUDY; DEPRESSION; FORCED SWIMMING TEST; LOCOMOTION; MALE; MAZE TEST; MOUSE; NONHUMAN; PLACE PREFERENCE; PREPULSE INHIBITION; PRIORITY JOURNAL; PROTEIN FUNCTION; SENSORIMOTOR FUNCTION; SENSORY GATING;

ANIMALS; BEHAVIOR, ANIMAL; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; EXPLORATORY BEHAVIOR; HINDLIMB SUSPENSION; INSECTICIDES; IVERMECTIN; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PAIN MEASUREMENT; PSYCHOMOTOR PERFORMANCE; RECEPTORS, PURINERGIC P2X4; SENSORY GATING; STATISTICS, NONPARAMETRIC; SWIMMING;

EID: 84878016110     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145712000909     Document Type: Article

References (62)

1. Antonio LS, Stewart AP, Xu XJ, Varanda WA, et al. (2011). P2X4 receptors interact with both P2X2 and P2X7 receptors in the form of homotrimers. British Journal of Pharmacology 163, 1069-1077.
2. Asatryan L, Nam HW, Lee MR, Thakkar MM, et al. (2011). Implication of the purinergic system in alcohol use disorders. Alcoholism, Clinical and Experimental Research 35, 584-594.
3. Asatryan L, Popova M, Perkins D, Trudell JR, et al. (2010). Ivermectin antagonizes ethanol inhibition in purinergic P2X4 receptors. Journal of Pharmacology and Experimental Therapeutics 334, 720-728.
4. Basudde CD (1989). Clinical signs and biochemical changes in calves caused by injection of ivermectin. Veterinary Quarterly 11, 29-32.
5. Baxter AW, Choi SJ, Sim JA, North RA (2011). Role of P2X4 receptors in synaptic strengthening in mouse CA1 hippocampal neurons. European Journal of Neuroscience 34, 213-220.
6. Belzung C, Le Pape G (1994). Comparison of different behavioral test situations used in psychopharmacology for measurement of anxiety. Physiology and Behavior 56, 623-628.
7. Bo X, Zhang Y, Nassar M, Burnstock G, et al. (1995). A P2X purinoceptor cDNA conferring a novel pharmacological profile. FEBS Letters 375, 129-133.
8. Borsini F, Meli A (1988). Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology 94, 147-160.
9. Bortolato M, Aru GN, Frau R, Orru M, et al. (2005). Kappa opioid receptor activation disrupts prepulse inhibition of the acoustic startle in rats. Biological Psychiatry 57, 1550-1558.
10. Bortolato M, Campolongo P, Mangieri RA, Scattoni ML, et al. (2006). Anxiolytic-like properties of the anandamide transport inhibitor AM404. Neuropsychopharmacology 31, 2652-2659.
11. Bortolato M, Frau R, Bini V, Luesu W, et al. (2010). Methamphetamine neurotoxicity increases brain expression and alters behavioral functions of CB cannabinoid receptors. Journal of Psychiatric Research 44, 944-955.
12. Bortolato M, Godar SC, Davarian S, Chen K, et al. (2009). Behavioral disinhibition and reduced anxiety-like behaviors in monoamine oxidase B-deficient mice. Neuropsychopharmacology 34, 2746-2757.
13. Buell G, Collo G, Rassendren F (1996). P2X receptors: an emerging channel family. European Journal of Neuroscience 8, 2221-2228.
14. Carola V, D'Olimpio F, Brunamonti E, Mangia F, et al. (2002). Evaluation of the elevated plus-maze and open-field tests for the assessment of anxiety-related behaviour in inbred mice. Behavioural Brain Research 134, 49-57.
15. Chatterjee M, Jaiswal M, Palit G (2012). Comparative evaluation of forced swim test and tail suspension test as models of negative symptom of schizophrenia in rodents. ISRN Psychiatry. Published online: 13 June 2012. doi:10.5402/2012/595141.
16. Castagné V, Moser P, Roux S, Porsolt RD (2011). Rodent models of depression: forced swim and tail suspension behavioral despair tests in rats and mice. Current Protocols in Neuroscience Unit 8, 10A.
17. Collins T, Millar NS (2010). Nicotinic acetylcholine receptor transmembrane mutations convert ivermectin from a positive to a negative allosteric modulator. Molecular Pharmacology 78, 198-204.
18. Cully DF, Vassilatis DK, Liu KK, Paress PS, et al. (1994). Cloning of an avermectin-sensitive glutamate-gated chloride channel from Caenorhabditis elegans. Nature 371, 707-711.
19. Davis JA, Paylor R, McDonald MP, Libbey M, et al. (1999). Behavioral effects of ivermectin in mice. Laboratory Animal Science 49, 288-296.
20. Dawson GR, Wafford KA, Smith A, Marshall GR, et al. (2000). Anticonvulsant and adverse effects of avermectin analogs in mice are mediated through the gamma-aminobutyric acid(A) receptor. Journal of Pharmacology and Experimental Therapeutics 295, 1051-1060.
21. de Spinosa HS, Stilck SR, Bernardi MM (2002). Possible anxiolytic effects of ivermectin in rats. Veterinary Research Communications 26, 309-321.
22. Geary TG (2005). Ivermectin 20 years on: maturation of a wonder drug. Trends in Parasitology 21, 530-532.
23. Gobbi G, Bambico FR, Mangieri R, Bortolato M, et al. (2005). Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proceedings of the National Academy of Sciences USA 102, 18620-18625.
24. Guo C, Masin M, Qureshi OS, Murrell-Lagnado RD (2007). Evidence for functional P2X4/P2X7 heteromeric receptors. Molecular Pharmacology 72, 1447-1456.
25. Huang J, Casida JE (1997). Avermectin B1a binds to high-and low-affinity sites with dual effects on the gamma-aminobutyric acid-gated chloride channel of cultured cerebellar granule neurons. Journal of Pharmacology and Experimental Therapeutics 281, 261-266.
26. Jo YH, Donier E, Martinez A, Garret M, et al. (2011). Cross-talk between P2X4 and gamma-aminobutyric acid, type A receptors determines synaptic efficacy at a central synapse. Journal of Biological Chemistry 286, 19993-20004.
27. Kalueff AV, Jensen CL, Murphy DL (2007). Locomotory patterns, spatiotemporal organization of exploration and spatial memory in serotonin transporter knockout mice. Brain Research 1169, 87-97.
28. Khakh BS, North RA (2006). P2X receptors as cell-surface ATP sensors in health and disease. Nature 442, 527-532.
29. Khakh BS, Proctor WR, Dunwiddie TV, Labarca C, et al. (1999). Allosteric control of gating and kinetics at P2X(4) receptor channels. Journal of Neuroscience 19, 7289-7299.
30. Kimpel MW, Strother WN, McClintick JN, Carr LG, et al. (2007). Functional gene expression differences between inbred alcohol-preferring and non-preferring rats in five brain regions. Alcohol 41, 95-132.
31. Krause RM, Buisson B, Bertrand S, Corringer PJ, et al. (1998). Ivermectin: a positive allosteric effector of the alpha7 neuronal nicotinic acetylcholine receptor. Molecular Pharmacology 53, 283-294.
32. Lorca RA, Rozas C, Loyola S, Moreira-Ramos S, et al. (2011). Zinc enhances long-term potentiation through P2X receptor modulation in the hippocampal CA1 region. European Journal of Neuroscience 33, 1175-1185.
33. Maldonado R, Saiardi A, Valverde O, Samad TA, et al. (1997). Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature 388, 586-589.
34. Nafstad I, Sannes E, Hem A, Engen PA, et al. (1991). Behavioural method to detect marginal neurotoxic effects of ivermectin in DA/Orl rats. Journal of Experimental Animal Science 34, 81-86.
35. Nagata K, Imai T, Yamashita T, Tsuda M, et al. (2009). Antidepressants inhibit P2X4 receptor function: a possible involvement in neuropathic pain relief. Molecular Pain 5, 20.
36. Nicke A, Kerschensteiner D, Soto F (2005). Biochemical and functional evidence for heteromeric assembly of P2X1 and P2X4 subunits. Journal of Neurochemistry 92, 925-933.
37. North RA (2002). Molecular physiology of P2X receptors. Physiological Reviews 82, 1013-1067.
38. Ormond SJ, Barrera NP, Qureshi OS, Henderson RM, et al. (2006). An uncharged region within the N terminus of the P2X6 receptor inhibits its assembly and exit from the endoplasmic reticulum. Molecular Pharmacology 69, 1692-1700.
39. Popova M, Asatryan L, Ostrovskaya O, Wyatt LR, et al. (2010). A point mutation in the ectodomain-transmembrane 2 interface eliminates the inhibitory effects of ethanol in P2X4 receptors. Journal of Neurochemistry 112, 307-317.
40. Priel A, Silberberg SD (2004). Mechanism of ivermectin facilitation of human P2X4 receptor channels. Journal of General Physiology 123, 281-293.
41. Prut L, Belzung C (2003). The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. European Journal of Pharmacology 463, 3-33.
42. Ramos A, Berton O, Mormede P, Chaouloff F (1997). A multiple-test study of anxiety-related behaviours in six inbred rat strains. Behavioural Brain Research 85, 57-69.
43. Richard-Lenoble D, Chandenier J, Gaxotte P (2003). Ivermectin and filariasis. Fundamental and Clinical Pharmacology 17, 199-203.
44. Rodgers RJ, Cole JC, Cobain MR, Daly P, et al. (1992). Anxiogenic-like effects of fluprazine and eltoprazine in the mouse elevated plus-maze: profile comparisons with 8-OH-DPAT, CGS 12066B, TFMPP and mCPP. Behavioural Pharmacology 3, 621-634.
45. Rubio ME, Soto F (2001). Distinct localization of P2X receptors at excitatory postsynaptic specializations. Journal of Neuroscience 21, 641-653.
46. Sattelle DB, Buckingham SD, Akamatsu M, Matsuda K, et al. (2009). Comparative pharmacology and computational modelling yield insights into allosteric modulation of human alpha7 nicotinic acetylcholine receptors. Biochemical Pharmacology 78, 836-843.
47. Scott AL, Bortolato M, Chen K, Shih JC (2008). Novel monoamine oxidase A knock out mice with human-like spontaneous mutation. Neuroreport 19, 739-743.
48. Shan Q, Haddrill JL, Lynch JW (2001). Ivermectin, an unconventional agonist of the glycine receptor chloride channel. Journal of Biological Chemistry 276, 12556-12564.
49. Sim JA, Chaumont S, Jo J, Ulmann L, et al. (2006). Altered hippocampal synaptic potentiation in P2X4 knock-out mice. Journal of Neuroscience 26, 9006-9009.
50. Sim JA, North RA (2010). Amitriptyline does not block the action of ATP at human P2X4 receptor. British Journal of Pharmacology 160, 88-92.
51. Soto F, Garcia-Guzman M, Karschin C, Stuhmer W (1996). Cloning and tissue distribution of a novel P2X receptor from rat brain. Biochemical and Biophysical Research Communications 223, 456-460.
52. Steru L, Chermat R, Thierry B, Mico JA, et al. (1987). The automated tail suspension test: a computerized device which differentiates psychotropic drugs. Progress in Neuro-Psychopharmacology and Biological Psychiatry 11, 659-671.
53. Sung YF, Huang CT, Fan CK, Lin CH, et al. (2009). Avermectin intoxication with coma, myoclonus, and polyneuropathy. Clinical Toxicology 47, 686-688.
54. Tabakoff B, Saba L, Printz M, Flodman P, et al. (2009). Genetical genomic determinants of alcohol consumption in rats and humans. BMC Biology 7, 70.
55. Toulme E, Garcia A, Samways D, Egan TM, et al. (2010a). P2X4 receptors in activated C8-B4 cells of cerebellar microglial origin. Journal of General Physiology 135, 333-353.
56. Toulme E, Tsuda M, Khakh BS, Inoue K (2010b). On the role of ATP-gated P2X receptors in acute, inflammatory and neuropathic pain. In: Kruger, L, Light, AR (Eds) Translational Pain Research: From Mouse to Man. Boca Raton, FL: CRC Press.
57. Tsuda M, Shigemoto-Mogami Y, Koizumi S, Mizokoshi A, et al. (2003). P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 424, 778-783.
58. Ulmann L, Hatcher JP, Hughes JP, Chaumont S, et al. (2008). Up-regulation of P2X4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain. Journal of Neuroscience 28, 11263-11268.
59. Vassilatis DK, Arena JP, Plasterk RH, Wilkinson HA, et al. (1997). Genetic and biochemical evidence for a novel avermectin-sensitive chloride channel in Caenorhabditis elegans. Isolation and characterization. Journal of Biological Chemistry 272, 33167-33174.
60. Yardley M, Wyatt L, Khoja S, Asatryan L, et al. (2012) Ivermectin reduces alcohol intake and preference in mice. Neuropharmacology 63, 190-201.
61. Zemkova H, Kucka M, Li S, Gonzalez-Iglesias AE, et al. (2010). Characterization of purinergic P2X4 receptor channels expressed in anterior pituitary cells. American Journal of Physiology. Endocrinology and Metabolism 298, E644-E651.
62. Zhang Z, Artelt M, Burnet M, Trautmann K, et al. (2006). Lesional accumulation of P2X4 receptor+monocytes following experimental traumatic brain injury. Experimental Neurology 197, 252-257.